Gardai Shyra J - Hlth Sci Ctr, Univ Colorado

基本信息

浏览量：18

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 89 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Figure S3 from Brentuximab Vedotin–Driven Microtubule Disruption Results in Endoplasmic Reticulum Stress Leading to Immunogenic Cell Death and Antitumor Immunity

Ryan A. Heiser,Anthony Cao,Weiping Zeng,Michelle Ulrich,Patrick Younan,Martha E. Anderson,Esther S. Trueblood,Mechthild Jonas,Robert Thurman,Che‐Leung Law,Shyra J. Gardai

openalex

引用0浏览0引用

Table S1 from Brentuximab Vedotin–Driven Microtubule Disruption Results in Endoplasmic Reticulum Stress Leading to Immunogenic Cell Death and Antitumor Immunity

Ryan A. Heiser,Anthony Cao,Weiping Zeng,Michelle Ulrich,Patrick Younan,Martha E. Anderson,Esther S. Trueblood,Mechthild Jonas,Robert Thurman,Che‐Leung Law,Shyra J. Gardai

openalex

引用0浏览0引用

Reversible Chemical Modification of Antibody Effector Function Mitigates Unwanted Systemic Immune Activation

Philip N. Moquist,Xinqun Zhang,Chris I. Leiske, Nicole M. -L. Eng-Duncan,Weiping Zeng,Noah A. Bindman,Serena W. Wo,Abbie Wong,Clark M. Henderson,Karalyne Crowder,Robert Lyon,Svetlana O. Doronina,Peter D. Senter,Haley D. Neff-LaFord,Django Sussman,Shyra J. Gardai,Matthew R. Levengood

Bioconjugate chemistry（2024）

引用0浏览0WOS引用

Data from Brentuximab Vedotin–Driven Microtubule Disruption Results in Endoplasmic Reticulum Stress Leading to Immunogenic Cell Death and Antitumor Immunity

Ryan A. Heiser,Anthony T. Cao,Weiping Zeng,Michelle Ulrich,Patrick Younan,Martha E. Anderson,Esther S. Trueblood,Mechthild Jonas,Robert Thurman,Che-Leung Law,Shyra J. Gardai

MOLECULAR CANCER THERAPEUTICSno. 1 (2024): 68-83

引用0浏览0WOS引用

Supplementary Data from Brentuximab Vedotin–Driven Microtubule Disruption Results in Endoplasmic Reticulum Stress Leading to Immunogenic Cell Death and Antitumor Immunity

Ryan A. Heiser,Anthony Cao,Weiping Zeng,Michelle Ulrich,Patrick Younan,Martha E. Anderson,Esther S. Trueblood,Mechthild Jonas,Robert Thurman,Che‐Leung Law,Shyra J. Gardai

openalex

引用0浏览0引用

Abstract 1866: Discovery of Mutation-Independent EGFR Degrading Bispecific Antibodies That Suppress Tumor Growth in Preclinical Tumor Models

Jonathan Sitrin, Lisa Marshall,Hai Tran,Kenneth Ng, Kimberly Hoi,Josef Gramespacher,Zhong Huang, Andy Goodrich,Filomena Housley, May Dayao,Man-Tzu Wang, Katarina Pance, Aleysha Chen,Kevin Carlin, Lichao Zhang, James Lee,Rami Hannoush,Ken Flanagan,Maia Vinogradova, Isaac Rondon,Shyra Gardai

Cancer researchno. 6_Supplement (2024): 1866-1866

引用0浏览0引用

Figure S4 from Brentuximab Vedotin–Driven Microtubule Disruption Results in Endoplasmic Reticulum Stress Leading to Immunogenic Cell Death and Antitumor Immunity

Ryan A. Heiser,Anthony Cao,Weiping Zeng,Michelle Ulrich,Patrick Younan,Martha E. Anderson,Esther S. Trueblood,Mechthild Jonas,Robert Thurman,Che‐Leung Law,Shyra J. Gardai

openalex（2024）

引用0浏览0引用

Figure S2 from Brentuximab Vedotin–Driven Microtubule Disruption Results in Endoplasmic Reticulum Stress Leading to Immunogenic Cell Death and Antitumor Immunity

Ryan A. Heiser,Anthony Cao,Weiping Zeng,Michelle Ulrich,Patrick Younan,Martha E. Anderson,Esther S. Trueblood,Mechthild Jonas,Robert Thurman,Che‐Leung Law,Shyra J. Gardai

openalex（2024）

引用0浏览0引用

Abstract 5676: SGN-BB228, a CD228-directed Costimulatory Antibody Anticalin® Bispecific Provides Potent and Conditional 4-1BB Costimulation to T Cells in Vivo and in an in Vitro Model of T Cell Exhaustion

Barrett Updegraff, Johannes Urban,James Mutschler,Gregory L. Szeto,Brian P. O’Connor,Shyra J. Gardai,Ryan A. Heiser

Cancer Researchno. 7_Supplement (2023): 5676-5676

引用0浏览0引用

Supplementary Figure 8 from Therapeutic and Prophylactic Antitumor Activity of an Oral Inhibitor of Fucosylation in Spontaneous Mammary Cancers

Mary L. Disis,Lauren R. Corulli,Ekram A. Gad,Marlese R. Koehnlein,Denise L. Cecil,Peter D. Senter,Shyra J. Gardai,Nicole M. Okeley

openalex（2023）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn